https://www.selleckchem.com/products/vt103.html
This analysis attempts to determine the diagnostic and prognostic value of bone marrow (BM) evaluation by multiparameter flow cytometry in patients with myelodysplastic syndrome (MDS). The study group consisted of patients who underwent diagnostic process in the years 2008-2017 due to cytopenia and finally were diagnosed with MDS (n=71). The comparative group included patients with cytopenia diagnosed in the same period, whose definitive diagnosis was other than MDS (n=39). Flow cytometric evaluation of BM was performed following the reco
Like
Comment
Share
